“Cisplatin (P)- including triplets versus P-free doublets in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC): SICOG 0101 randomized trial”

Research output: Contribution to conferenceOther

Original languageUndefined/Unknown
Pages389s-389s
Publication statusPublished - 2006

Cite this